Clinical features of children with juvenile idiopathic arthritis using the ILAR classification criteria: A community-based cohort study in Taiwan

Journal of Microbiology, Immunology and Infection

Volumn 46, Issue 4, 2013, Pages 288-294

  Shen, Chang Ching ^a   Yeh, Kuo Wei ^a   Ou, Liang Shiou ^a   Yao, Tsung Chieh ^a   Chen, Li Chen ^a   Huang, Jing Long ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Classification criteria; Juvenile rheumatoid arthritis; Pediatric rheumatic disease

Indexed keywords

ADALIMUMAB; CORTICOSTEROID; ETANERCEPT; METHOTREXATE; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE;

ARTHRALGIA; ARTICLE; BIOLOGICAL THERAPY; CHINESE; CLINICAL FEATURE; COMMUNITY CARE; DISEASE ACTIVITY; DISEASE CLASSIFICATION; ENTHESITIS; GEOGRAPHIC DISTRIBUTION; HUMAN; INTERNATIONAL LEAGUE OF ASSOCIATIONS FOR RHEUMATOLOGY; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; POLYARTHRITIS; PSORIATIC ARTHRITIS; TAIWAN; UVEITIS;

EID: 84882262824     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2012.03.006     Document Type: Article

References (34)

1. Wu C.J., Huang J.L., Yang M.H., Yan D.C., Ou L.S., Ho H.H. Clinical characteristics of juvenile rheumatoid arthritis in Taiwan. J Microbiol Immunol Infect 2001, 34:211-214.
2. Fink C.W. Proposal for the development of classification criteria for idiopathic arthritides of childhood. J Rheumatol 1995, 22:1566-1569. and the ILAR Task Force for Classification Criteria.
3. Petty R.E., Southwood T.R., Baum J., Bhettay E., Glass D., Manners P., et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 1998, 25:1991-1994.
4. Petty R.E., Southwood T.R., Manners P., Baum J., Glass D.N., Goldenberg J., et al. International League of Associations for rheumatology classification of juvenile idiopathic arthritis: 2nd revision, Edmonton, 2001. J Rheumatol 2004, 31:390-392.
5. Huang J.L., Yao T.C., See L.C. Prevalence of pediatric systemic lupus erythematosus and juvenile chronic arthritis in a Chinese population: a nationwide prospective population based study in Taiwan. Clin Exp Rheumatol 2004, 22:776-780.
6. Wallace C.A., Ruperto N., Giannini E. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol 2004, 31:2290-2294.
7. Kunjir V., Venugopalan A., Chopra A. Profile of Indian patients with juvenile onset chronic inflammatory joint disease using the ILAR classification criteria for JIA: a community-based cohort study. J Rheumatol 2010, 37:1756-1762.
8. Demirkaya E., Ozen S., Bilginer Y., Ayaz N.A., Makay B.B., Unsal E., et al. The distribution of juvenile idiopathic arthritis in the eastern Mediterranean: results from the registry of the Turkish Paediatric Rheumatology Association. Clin Exp Rheumatol 2011, 29:111-116.
9. Nordal E., Zak M., Aalto K., Berntson L., Fasth A., Herlin T., et al. Ongoing disease activity and changing categories in a long-term Nordic cohort study of juvenile idiopathic arthritis. Arthritis Rheum 2011, 63:2809-2818.
10. Modesto C., Antón J., Rodriguez B., Bou R., Arnal C., Ros J., et al. Incidence and prevalence of juvenile idiopathic arthritis in Catalonia (Spain). Scand J Rheumatol 2010, 39:472-479.
11. Hofer M.F., Mouy R., Prieur A.M. Juvenile idiopathic arthritides evaluated prospectively in a single center according to the Durban criteria. J Rheumatol 2001, 28:1083-1090.
12. Krumrey-Langkammer M., Hafner R. Evaluation of the ILAR criteria for juvenile idiopathic arthritis. J Rheumatol 2001, 28:2544-2547.
13. Arguedas O., Fasth A., Andersson-Gäre B. A prospective population based study on outcome of juvenile chronic arthritis in Costa Rica. J Rheumatol 2002, 29:174-183.
14. Ramsey S., Bolaria R., Cabral D., Malleson P., Petty R. Comparison of criteria for the classification of childhood arthritis. J Rheumatol 2000, 27:1283-1286.
15. Heiligenhaus A., Niewerth M., Ganser G., Heinz C., Minden K. German Uveitis in Childhood Study Group. Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Rheumatology (Oxford) 2007, 46:1015-1019.
16. Chalom E.C., Goldsmith D.P., Koehler M.A., Bittar B., Rose C.D., Ostrov B.E., et al. Prevalence and outcome of uveitis in a regional cohort of patients with juvenile rheumatoid arthritis. J Rheumatol 1997, 24:2031-2034.
17. Shin J.I., Kim K.H., Chun J.K., Lee T.J., Kim K.J., Kim H.S., et al. Prevalence and patterns of anti-nuclear antibodies in Korean children with juvenile idiopathic arthritis according to ILAR criteria. Scand J Rheumatol 2008, 37:348-351.
18. Fujikawa S., Okuni M. Clinical analysis of 570 cases with juvenile rheumatoid arthritis: results of a nationwide retrospective survey in Japan. Acta Paediatr Jpn 1997, 39:245-249.
19. Zak M., Pedersen F.K. Juvenile chronic arthritis into adulthood: a long-term follow-up study. Rheumatology (Oxford) 2000, 39:198-204.
20. Oen K., Malleson P.N., Cabral D.A., Rosenberg A.M., Petty R.E., Cheang M. Disease course and outcome of juvenile rheumatoid arthritis in a multicenter cohort. J Rheumatol 2002, 29:1989-1999.
21. Lovell D.J., Giannini E.H., Reiff A., Cawkwell G.D., Silverman E.D., Nocton J.J., et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. N Engl J Med 2000, 342:763-769.
22. Wallace C.A. Developing standards of care for patients with juvenile idiopathic arthritis. Rheumatology (Oxford) 2010, 49:1213-1214.
23. Beresford M.W., Cleary A.G., Foster H.E., Hutchinson E., Baildam E.M., Davies K. Comment on: developing standards of care for patients with juvenile idiopathic arthritis. Rheumatology (Oxford) 2010, 49:2227-2229.
24. Ruperto N., Lovell D.J., Quartier P., Paz E., Rubio-Perez N., Silva C.A., et al. Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis. Arthritis Rheum 2010, 62:1792-1802.
25. Shenoi S., Wallace C.A. Tumor necrosis factor inhibitors in the management of juvenile idiopathic arthritis: an evidence-based review. Paediatr Drugs 2010, 12:367-377.
26. Cron R.Q., Sharma S., Sherry D.D. Current treatment by United States and Canadian pediatric rheumatologists. J Rheumatol 1999, 26:2036-2038.
27. Huang J.L., Chen L.C. Sulphasalazine in the treatment of children with chronic arthritis. Clin Rheumatol 1998, 17:359-363.
28. Lin Y.T., Yang Y.H., Tsai M.J., Chiang B.L. Long-term effects of azathioprine therapy for juvenile rheumatoid arthritis. J Formos Med Assoc 2000, 99:330-335.
29. Petty R.E., Cassidy J.T., Sullivan D.B. Clinical correlates of antinuclear antibodies in juvenile rheumatoid arthritis. J Pediatr 1973, 83:386-389.
30. Rosenberg A.M. The clinical associations of antinuclear antibodies in juvenile rheumatoid arthritis. Clin Immunol Immunopathol 1988, 49:19-27.
31. Szer W., Sierakowska H., Szer I.S. Antinuclear antibody profile in juvenile rheumatoid arthritis. J Rheumatol 1991, 18:401-408.
32. Ravelli A., Varnier G.C., Oliveira S., Castell E., Arguedas O., Magnani A., et al. Antinuclear antibody-positive patients should be grouped as a separate category in the classification of juvenile idiopathic arthritis. Arthritis Rheum 2011, 63:267-275.
33. Hsu C.T., Lin Y.T., Yang Y.H., Chiang B.L. Factors affecting clinical and therapeutic outcomes of patients with juvenile rheumatoid arthritis. Scand J Rheumatol 2004, 33:312-317.
34. Pruunsild C., Uibo K., Liivamägi H., Tarraste S., Talvik T., Pelkonen P. Incidence of juvenile idiopathic arthritis in children in Estonia: a prospective population-based study. Scand J Rheumatol 2007, 36:7-13.